Table 4 Association between pathogens and patients’ demographic and clinical characteristics

N

353

11

7

3

14

8

6

4

8

28

 male

246 (69.69%)

10 (90.91%)

3 (42.86%)

3 (100.00%)

10 (71.43%)

4 (50.00%)

3 (50.00%)

2 (50.00%)

4 (50.00%)

20 (71.43%)

 female

107 (30.31%)

1 (9.09%)

4 (57.14%)

0 (0.00%)

4 (28.57%)

4 (50.00%)

3 (50.00%)

2 (50.00%)

4 (50.00%)

8 (28.57%)

Age (years)

7.8 ± 4.1

8.4 ± 3.1

10.2 ± 2.6

5.4 ± 3.6

6.5 ± 5.2

6.8 ± 4.5

7.6 ± 3.8

8.3 ± 5.2

6.8 ± 3.9

7.9 ± 3.5

 yes

302 (85.55%)

8 (72.73%)

5 (71.43%)

3 (100.00%)

10 (71.43%)

7 (87.50%)

4 (66.67%)

3 (75.00%)

6 (75.00%)

21 (75.00%)

 no

51 (14.45%)

3 (27.27%)

2 (28.57%)

0 (0.00%)

4 (28.57%)

1 (12.50%)

2 (33.33%)

1 (25.00%)

2 (25.00%)

7 (25.00%)

Duration of fever (days)

4.9 ± 2.8

5.7 ± 3.2

3.5 ± 2.6

4.3 ± 3.2

3.8 ± 2.3

4.5 ± 1.9

5.6 ± 2.4

4.1 ± 2.6

4.7 ± 2.6

4.5 ± 2.4

Duration of cough (days)

10.2 ± 6.2

8.6 ± 5.8

13.6 ± 6.5

10.3 ± 6.9

11.8 ± 9.3

8.9 ± 4.3

10.1 ± 6.8

8.2 ± 4.3

9.4 ± 7.6

11.3 ± 6.4

 Yes

122 (34.56%)

3 (27.27%)

0 (0.00%)

0 (0.00%)

1 (7.14%)

2 (25.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

2 (7.14%)

 No

231 (65.44%)

8 (72.73%)

7 (100.00%)

3 (100.00%)

13 (92.86%)

6 (75.00%)

6 (100.00%)

4 (100.00%)

8 (100.00%)

26 (92.86%)

 yes

120 (33.99%)

3 (27.27%)

2 (28.57%)

0 (0.00%)

4 (28.57%)

2 (25.00%)

2 (33.33%)

1 (25.00%)

3 (37.50%)

9 (32.14%)

 no

233 (66.01%)

8 (72.73%)

5 (71.43%)

3 (100.00%)

10 (71.43%)

6 (75.00%)

4 (66.67%)

3 (75.00%)

5 (62.50%)

19 (67.86%)

 Yes

15 (4.25%)

2 (18.18%)

1 (14.29%)

0 (0.00%)

1 (7.14%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

1 (12.50%)

1 (3.70%)

 no

340 (96.32%)

9 (81.82%)

6 (85.71%)

3 (100.00%)

13 (92.86%)

8 (100.00%)

6 (100.00%)

4 (100.00%)

7 (87.50%)

27 (96.43%)

 Yes

102 (28.90%)

0 (0.00%)

0 (0.00%)

1 (33.33%)

2 (14.29%)

1 (12.50%)

0 (0.00%)

0 (0.00%)

1 (12.50%)

3 (10.71%)

 Erythematous maculopapular rash

20 (5.67%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

2 (7.14%)

 Liver lesion

46 (13.03%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

 Kidney lesion

9 (2.55%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

 Neurological complications

79 (22.38%)

0 (0.00%)

0 (0.00%)

1 (33.33%)

2 (14.29%)

1 (12.50%)

0 (0.00%)

0 (0.00%)

1 (12.50%)

1 (3.57%)

 no

251 (71.10%)

11 (100.00%)

7 (100.00%)

2 (66.67%)

12 (85.71%)

7 (87.50%)

6 (100.00%)

4 (100.00%)

7 (87.50%)

25 (89.29%)

 abnormal

245 (69.41%)

5 (45.45%)

4 (57.14%)

2 (66.67%)

6 (42.86%)

5 (62.50%)

2 (33.33%)

2 (50.00%)

4 (50.00%)

27 (96.43%)

 normal

108 (30.59%)

6 (54.55%)

3 (42.86%)

1 (33.33%)

8 (57.14%)

3 (37.50%)

4 (66.67%)

2 (50.00%)

4 (50.00%)

1 (3.57%)

 abnormal

36 (10.20%)

1 (9.09%)

2 (28.57%)

0 (0.00%)

1 (7.14%)

1 (12.50%)

0 (0.00%)

1 (25.00%)

2 (25.00%)

3 (10.71%)

 normal

317 (89.80%)

10 (90.91%)

5 (71.43%)

3 (100.00%)

13 (92.86%)

7 (87.50%)

6 (100.00%)

3 (75.00%)

6 (75.00%)

25 (89.29%)

 abnormal

81 (22.95%)

3 (27.27%)

2 (28.57%)

1 (33.33%)

4 (28.57%)

3 (37.50%)

2 (33.33%)

1 (25.00%)

3 (37.50%)

24 (85.71%)

 normal

272 (77.05%)

8 (72.73%)

5 (71.43%)

2 (66.67%)

10 (71.43%)

5 (62.50%)

4 (66.67%)

3 (75.00%)

5 (62.50%)

4 (14.29%)

Duration of hospitalization (days)

15.8 ± 4.1

14.2 ± 4.3

13.6 ± 5. 8

12.5 ± 3.6

14.9 ± 5.2

15.1 ± 3.7

13.9 ± 6.2

14.7 ± 5.1

14.6 ± 2.4

15.3 ± 4.4